MSF starts trials of Ebola candidates
November 14, 2014Research and Development, Sales and Marketing Ebola, MSF, Médecins Sans Frontières, avigan, brincidofovir, favipiravir
Three experimental Ebola therapies will be tested at sites operated by Médecins Sans Frontières (MSF) in West Africa, according to …
EMA responds to redaction concerns
November 14, 2014Sales and Marketing AbbVie, EMA, Goldacre, Humira, Rasi, adalimumab, redactions, transparency
The EMA has published a response to European Ombudsman Emily O’Reilly’s questions about some of its trial data redactions. O’Reilly’s …
Cost of NHS medicines rises
November 14, 2014Sales and Marketing HSCIC, NHS, NICE, PPRS, drugs, hospitals, spend
Hospitals in England are taking an increasing share of the NHS’s bill for drugs approved by NICE, according to a …
Actavis appoints Pepsi head as CFO amid takeover talk
November 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, maria moen, pepsi
Dublin-based speciality pharma firm Actavis which is currently in talks to buy Allergan for $60 billion, has hired a chief …
NHS to ‘kitemark’ health-related apps
November 13, 2014Medical Communications, Sales and Marketing Apple, Hunt, NHS, Samsung, apps, kitemark, wearables
Plans to improve the quality of patient care by introducing a ‘kitemark’ to safely validate healthcare apps have been announced …
Allergan eyeing Actavis buyout
November 13, 2014Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Botox, Valeant, acquisition, buyout, merger
Allergan is attempting to block a recent Valeant hostile takeover bid by seeking the rumoured alternative merger deal with Actavis, …
Charity ‘deeply concerned’ on CDF changes
November 13, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, breakthrough breast cancer, palframan
A leading cancer charity has warned that a number of key drugs are at risk of being withdrawn from patients …
Laser testing could lead to improved asthma therapies
November 13, 2014Research and Development, Sales and Marketing Oxford, asthma, pmdis, pope, stfc
UK scientists have used a laser beam trap to examine how drug particles from asthma inhalers travel through the air …
GE and Takeda make liver pact
November 13, 2014Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash
GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …
VorroHealth hires VP of Care Innovation
November 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing maria moen, vorrohealth
VorroHealth the healthcare clinical tech provider firm has appointed Maria Moen to the newly-created position of vice president of Care Innovation. Moen …
Horizon forms new cancer advisory board
November 12, 2014Research and Development, Sales and Marketing Cambridge, Horizon Discovery, Karin Schmitt, Paul Morrill, biotech, sab
UK biotech Horizon Discovery has formed a new Scientific Advisory Board (SAB) for its diagnostics arm to recommend better cancer …
Numerous prospects in health technology say analysts
November 12, 2014Medical Communications, Sales and Marketing 3D, AstraZeneca, F&S, app, digital, frost and sullivan, fs, wearables
Medical devices and imaging technology have been included in a recent analysis of the top 50 most innovative technologies. Frost …
Dendreon files for bankruptcy
November 12, 2014Research and Development, Sales and Marketing Dendreon, Provenge, awick, delaware, johnson, nj
Dendreon Corporation, the troubled manufacturer of high-cost cancer vaccine Provenge, has filed for bankruptcy as a prelude to restructuring its …
NHS Better Care Fund lacks guidance, says watchdog
November 12, 2014Sales and Marketing England, NHS, UK, better care fund, nao
A much-lauded project to reduce unnecessary hospital visits and shift care into the community will fall well short of its …
Doctors warn of urgent care ‘chaos’
November 12, 2014Sales and Marketing BMA, GPs, NHS, doctors, nagpaul, pac
Doctors’ leaders are demanding greater investment in out-of-hours GP services, warning of ‘fragmentation’ and underfunding, and branding the current system …
Theorem appoints two vice presidents
November 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Angela Weston, Kathryn Bohannon, theorem
Contract research organisation Theorem has named Kathryn Bohannon as vice president of its biopharma development unit, and Angela Weston as …
Eisai: Fycompa decision ‘deeply regrettable’
November 11, 2014Research and Development, Sales and Marketing Eisai, Fycompa, Germany, epilepsy, gba, perampanel
Eisai has lashed out at a major German health assessment body, calling its stance on first-in-class epilepsy treatment Fycompa ‘deeply …
FDA decides on format for facility registrations
November 11, 2014Manufacturing and Production FDA, fdasia, gln, gs1, manufacturing, ufi
The US FDA has finalised the details of its registration scheme for pharma manufacturing facilities, which aims to make it …
GPs to ‘prescribe’ apps
November 11, 2014Medical Communications, Sales and Marketing Apple, Frost & Sullivan, GPs, NHS, Samsung, UK, apps, eHealth, prescribing
General practitioners in the UK are to begin ‘prescribing’ health apps as part of a move to better monitor issues …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
